ECHO IQ

Echo IQ is proud to partner with leading institutions around the world, collaboratively creating new research innovations, commercial opportunities, and improving health outcomes... Echo IQ has developed a cloud-based decision-support software, EchoSolv™, powered by Artificial Intelligence and Machine Learning, which aims to provide physicians with a reliable tool to identify patients at-risk of structural heart disease who may benefit for further referral. EchoSolv™ aims to improve the current standard clinical workflow associated with diagnosis and treatment... The Echo IQ screening program applies innovation and a proprietary algorithm to produce risk assessments for patients using their echocardiographic measurements. We harness the power of AI to produce consistent outputs at speed, and without bias. Applied to the identification of aortic stenosis, for example, EchoSolv has been designed to identify patients at risk of mortality who might benefit from further clinical review...

Also known as: Echo IQ Limited

Registration numbers: 48 142 901 353 (W)

Primary location: Sydney Australia